@inproceedings{inproceedings, title  = {{Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group}},

 url = {{}},

 year = {{2005}},

 month = {{3}},

 author = {{Dark GG and Calvert AH and Grimshaw R and Poole C and Swenerton K and Kaye S and Coleman R and Jayson G and Le T and Ellard S and Trudeau M et al}},

 doi = {{10.1200/JCO.2005.02.028}},

 volume = {{23}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{9}},

 pages = {{1859-1866}},

 note = {{Accessed on 2025/10/10}}}